Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Simmonds

Showing results (601-610 of 612) with videos related to

Pageof 62
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 2, 2026
Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosisEva Van Braeckel, Andrew T Braun, Nicholas J Simmonds, et al.
The Journal of Clinical Endocrinology and Metabolism|May 21, 2014
Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and EuropeAlexander Hamilton, Paul R Newby, Jacqueline D Carr-Smith, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2024
ECFS standards of care on CFTR-related disorders: Identification and care of the disordersN J Simmonds, K W Southern, E De Wachter, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2026
Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter surveyAndrea Gramegna, Carlo Magnoni, Chiara Premuda, et al.
Nature|May 24, 2013
Negligible impact of rare autoimmune-locus coding-region variants on missing heritabilityKaren A Hunt, Vanisha Mistry, Nicholas A Bockett, et al.
Nature Genetics|June 8, 2007
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetesJohn A Todd, Neil M Walker, Jason D Cooper, et al.
Nature|January 6, 2022
Emergence of methicillin resistance predates the clinical use of antibioticsJesper Larsen, Claire L Raisen, Xiaoliang Ba, et al.
Nature Genetics|December 28, 2011
Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestryKaren A Hunt, Deborah J Smyth, Tobias Balschun, et al.
The Lancet. Respiratory Medicine|July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trialEric W F W Alton, David K Armstrong, Deborah Ashby, et al.
Plos Genetics|March 4, 2014
Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid diseaseMarco Medici, Eleonora Porcu, Giorgio Pistis, et al.
Pageof 62

Showing results (601-610 of 612) with videos related to

Sort By:
Pageof 62
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 2, 2026
Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosisEva Van Braeckel, Andrew T Braun, Nicholas J Simmonds, et al.
The Journal of Clinical Endocrinology and Metabolism|May 21, 2014
Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and EuropeAlexander Hamilton, Paul R Newby, Jacqueline D Carr-Smith, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2024
ECFS standards of care on CFTR-related disorders: Identification and care of the disordersN J Simmonds, K W Southern, E De Wachter, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2026
Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter surveyAndrea Gramegna, Carlo Magnoni, Chiara Premuda, et al.
Nature|May 24, 2013
Negligible impact of rare autoimmune-locus coding-region variants on missing heritabilityKaren A Hunt, Vanisha Mistry, Nicholas A Bockett, et al.
Nature Genetics|June 8, 2007
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetesJohn A Todd, Neil M Walker, Jason D Cooper, et al.
Nature|January 6, 2022
Emergence of methicillin resistance predates the clinical use of antibioticsJesper Larsen, Claire L Raisen, Xiaoliang Ba, et al.
Nature Genetics|December 28, 2011
Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestryKaren A Hunt, Deborah J Smyth, Tobias Balschun, et al.
The Lancet. Respiratory Medicine|July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trialEric W F W Alton, David K Armstrong, Deborah Ashby, et al.
Plos Genetics|March 4, 2014
Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid diseaseMarco Medici, Eleonora Porcu, Giorgio Pistis, et al.
Pageof 62